Safe Orthopaedics confirms the acquisition of LCI Medical and holds its General Assembly on July 24th, 2020

• The financing of the operation is secured thanks to the support of Alpha Blue Ocean
• The acquisition of LCI Medical has been confirmed by the board of directors on June 12^th, 2020
• Several manufacturers confirm their interest in this new group

Eragny-sur-Oise, France, June 16^th, 2020, 17h45 CEST – Safe Orthopaedics (FR0013467123 - ALSAF), a company specializing in the design and marketing of ready-to-use technologies for spinal surgeries, delivering the safest treatment of spinal fractures urgently treated, confirms the acquisition of LCI Medical following the decision of the board of directors on June 12^th, 2020, and the strengthening of its cash position thanks to the support of Alpha Blue Ocean (“ABO”).

Creationg of a leader group for ready-to-use technologies

As announced to the market on May 6^th, 2020, Safe Orthopaedics wishes to consolidate an integrated leading group on ready-to-use technologies:

Innovative and pioneer, Safe Orthopaedics was the first player to make available “ready-to-use” kits (implants and instruments) for spinal surgeries to orthopaedic surgeons.

The combination with LCI Medical will allow Safe Orthopaedics to refocus its design, production and shipping to hospitals activities on two French sites, to accelerate the pace of development of new products for spine, but also to deploy its know-how on ready-to-use technologies in other orthopaedics segments, through different methods: on its behalf, through subcontracting and for third parties, as original equipment manufacturer, or in the framework of co-developments.

Since the announcement of its intention to acquire LCI Medical, the company has noticed expressions of interest for this new group and initiated discussions with other manufacturers in order to co-develop and to propose to hospitals across the globe more and more ready-to-use technologies.

Holding of the Shareholders’ Meeting on July 24^th, 2020

Safe Orthopaedics announces to its shareholders the holding of its Combined Annual General Meeting in its head office on Friday July 24^th, 2020,   annonce à ses actionnaires la tenue de son Assemblée Générale annuelle mixte (« AGM ») à son siège social le vendredi 24 juillet 2020, held in close session in accordance with the regulation on fight against Covid-19 epidemic.